| PERIOD ENDING | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | 27-Sep-08 | | Total Revenue | 31,123 | 23,757 | 26,792 | 34,626 | | Cost of Revenue | 20,690 | 22,051 | 15,635 | (3,743) | | | Gross Profit | 10,433 | 1,706 | 11,157 | 38,369 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,031 | 2,303 | 9,866 | 34,786 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 917 | 864 | 906 | 938 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,485 | (1,461) | 385 | 2,645 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 173 | 52 | 562 | 614 | | Earnings Before Interest And Taxes | 2,658 | (1,409) | 947 | 3,132 | | Interest Expense | 11 | 11 | 12 | 13 | | Income Before Tax | 2,647 | (1,420) | 935 | 3,119 | | Income Tax Expense | 962 | (584) | 324 | 978 | | Minority Interest | (88) | 125 | 236 | (125) | | | | Net Income From Continuing Ops | 1,597 | (711) | 847 | 2,016 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (4) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,597 | (711) | 847 | 2,012 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,597 | ($711) | $847 | $2,012 |
|
0.31% Nasdaq 
0.05%
Income Statement
